Pacific Shuanglin Bio pharmacy Co Ltd

SHE:000403 China Biotechnology
Market Cap
$1.84 Billion
CN¥13.52 Billion CNY
Market Cap Rank
#7180 Global
#1195 in China
Share Price
CN¥14.23
Change (1 day)
-0.21%
52-Week Range
CN¥13.11 - CN¥25.55
All Time High
CN¥49.14
About

Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in research, development, production, and sales of blood products in China and internationally. The company offers human serum albumin, intravenous human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus and anti-tetanus human immunoglobulin, rabies patient immunoglobulin, human c… Read more

Pacific Shuanglin Bio pharmacy Co Ltd (000403) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.009x

Based on the latest financial reports, Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.28 Million) by net assets (CN¥8.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pacific Shuanglin Bio pharmacy Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Pacific Shuanglin Bio pharmacy Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Pacific Shuanglin Bio pharmacy Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pacific Shuanglin Bio pharmacy Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥7.92 Billion CN¥321.79 Million 0.041x -55.58%
2023-12-31 CN¥7.42 Billion CN¥679.01 Million 0.091x +19.74%
2022-12-31 CN¥6.86 Billion CN¥524.22 Million 0.076x +18.43%
2021-12-31 CN¥6.33 Billion CN¥408.22 Million 0.065x -67.99%
2020-12-31 CN¥966.91 Million CN¥194.84 Million 0.202x -15.36%
2019-12-31 CN¥801.60 Million CN¥190.84 Million 0.238x +26.45%
2018-12-31 CN¥619.48 Million CN¥116.63 Million 0.188x +393.01%
2017-12-31 CN¥558.88 Million CN¥-35.91 Million -0.064x -156.24%
2016-12-31 CN¥546.91 Million CN¥62.49 Million 0.114x -14.61%
2015-12-31 CN¥525.49 Million CN¥70.31 Million 0.134x -20.34%
2014-12-31 CN¥458.65 Million CN¥77.04 Million 0.168x -35.09%
2013-12-31 CN¥351.68 Million CN¥91.01 Million 0.259x -39.60%
2012-12-31 CN¥287.68 Million CN¥123.24 Million 0.428x -6.92%
2011-12-31 CN¥282.74 Million CN¥130.14 Million 0.460x +1176.66%
2010-12-31 CN¥274.00 Million CN¥9.88 Million 0.036x -95.56%
2009-12-31 CN¥137.64 Million CN¥111.86 Million 0.813x +92.34%
2008-12-31 CN¥177.26 Million CN¥74.90 Million 0.423x -95.59%
2007-12-31 CN¥9.92 Million CN¥95.03 Million 9.578x +2397.05%
2006-12-31 CN¥-27.16 Million CN¥-10.42 Million 0.384x -12.05%
2005-12-31 CN¥112.49 Million CN¥49.06 Million 0.436x +299.35%
2004-12-31 CN¥602.14 Million CN¥-131.73 Million -0.219x -271.64%
2003-12-31 CN¥840.33 Million CN¥-49.47 Million -0.059x -128.81%
2002-12-31 CN¥779.03 Million CN¥159.18 Million 0.204x +26.30%
2001-12-31 CN¥687.82 Million CN¥111.28 Million 0.162x +254.33%
2000-12-31 CN¥599.28 Million CN¥27.36 Million 0.046x +195.34%
1999-12-31 CN¥481.83 Million CN¥-23.08 Million -0.048x -326.45%
1998-12-31 CN¥235.63 Million CN¥-2.65 Million -0.011x --